Artificial Intelligence in Genomics Market Size, Share, Revenue Report 2026 to 2035
What is Artificial Intelligence in Genomics Market Size?
The Artificial Intelligence in Genomics Market Size is valued at USD 1,032.90 Million in 2025 and is predicted to reach USD 57,744.31 Million by the year 2035 at a 50.8 % CAGR during the forecast period for 2026 to 2035.
Artificial Intelligence in Genomics Market Size, Share & Trends Analysis Report By Offering (Software, Services), By Functionality, By Technology, By Application, By End-User, By Region, And Segment Forecasts, 2026 to 2035.

Artificial Intelligence in Genomics Market Key Takeaways:
|
Market Segmentation
The Global Artificial Intelligence in Genomics market is segmented on the basis of offering, application, technology type, functionality, and region. Based on the offering, the AI in the genomics market is divided into Software, Services. Based on the application, the AI in the genomics market is divided into Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Other Applications. On the basis of technology, the market is segmented into Machine Learning and Other Technologies. Machine Learning is further segmented into Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other Machine Learning Technologies.
The growing research and development activities for the development of advanced treatment to treat various diseases and the high application of machine learning and deep learning in drug development are expected to the market growth significantly in the coming years. By Functionality, the market is segmented into Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine. By end-user, the market is segmented into Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes & Government Organizations, and Other End-Users. The growing adoption of AI in the large number of companies operating in drug development and research activities is expected to propel the growth AI in the genomics market significantly.
Based on the region, the market is segmented into Latin America, Asia Pacific, Middle East & Africa, North America, and Europe. In 2019, North America accounted for the largest share in AI in the genomics market, followed by Europe.
Competitive Landscape
Some Of The Key Players In The Artificial Intelligence in Genomics Market:
- AI Therapeutics, Inc.,
- Ares Genetics GmbH,
- BenevolentAI,
- BioSymetrics,
- Cambridge Cancer Genomics (UK),
- Clover Therapeutics,
- Congenica Ltd,
- Coral Genomics,
- CureMatch, Inc.,
- Cyclica Inc.,
- Data4Cure, Inc,
- Deep Genomics,
- Desktop Genetics Ltd.,
- Diploid (Belgium),
- DNAnexus,
- Emedgene,
- Empiric Logic,
- Engine Biosciences Pte. Ltd.,
- Fabric Genomics, Inc.,
- FDNA Inc. (US),
- Freenome Holdings, Inc.,
- Genoox, Ltd.,
- IBM (US),
- LifebitAI,
- Microsoft (Project Hanover),
- MolecularMatch Inc. (US),
- NVIDIA Corporation (US),
- PrecisionLife Ltd,
- Predictive Oncology,
- SOPHiA GENETICS, Inc.,
- Trace Genomics,
- Verge Genomics,
- WhiteLab Genomics,
- WuXi Nextcode Genomics

The Artificial Intelligence in Genomics Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 1,032.90 Million |
| Revenue Forecast In 2035 | USD 57,744.31 Million |
| Growth Rate CAGR | CAGR of 50.8 % from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Offering, By Functionality, By Technology, By Application, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | AI Therapeutics, Inc., Ares Genetics GmbH, BenevolentAI, BioSymetrics, Cambridge Cancer Genomics (UK), Clover Therapeutics, Congenica Ltd, Coral Genomics, CureMatch, Inc., Cyclica Inc., Data4Cure, Inc, Deep Genomics, Desktop Genetics Ltd., Diploid (Belgium), DNAnexus, Emedgene, Empiric Logic, Engine Biosciences Pte. Ltd., Fabric Genomics, Inc., FDNA Inc. (US), Freenome Holdings, Inc., Genoox, Ltd., IBM (US), LifebitAI, Microsoft (Project Hanover), MolecularMatch Inc. (US), NVIDIA Corporation (US), PrecisionLife Ltd, Predictive Oncology, SOPHiA GENETICS, Inc., Trace Genomics, Verge Genomics, WhiteLab Genomics, WuXi Nextcode Genomics |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Artificial Intelligence (AI) in Genomics Market Segmentation
Global Artificial Intelligence (AI) in Genomics Market by Offering
- Software
- Services

Global Artificial Intelligence (AI) in Genomics Market by Applications
- Diagnostics
- Drug Discovery & Development
- Precision Medicine
- Agriculture & animal Research
- Other Applications
Global Artificial Intelligence (AI) in Genomics Market by Technology
- Machine Learning
- Deep Learning
- Supervised Learning
- Reinforcement Learning
- Unsupervised Learning
- Other Machine Learning Technologies
- Other Technologies
Global Artificial Intelligence (AI) in Genomics Market by Functionality
- Genome Sequencing
- Gene Editing
- Clinical Workflows
- Predictive Genetic Testing & Preventive Medicine
Global Artificial Intelligence (AI) in Genomics Market by End-Users
- Pharmaceutical & Biotech Companies
- Healthcare Providers
- Research Centers, Academic Institutes & Government Organizations
- Other End-Users
Global Artificial Intelligence in Genomics Market Based on Region
Europe Artificial Intelligence in Genomics Market
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
North America Artificial Intelligence in Genomics Market
- U.S.
- Canada
Asia Pacific Artificial Intelligence in Genomics Market
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Artificial Intelligence in Genomics Market
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Artificial Intelligence in Genomics Market
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Artificial Intelligence in Genomics Market Size is valued at 1,032.90 Million in 2025 and is predicted to reach 57,744.31 Million by the year 2035.
The Artificial Intelligence in Genomics Market is expected to grow at a 50.8 % CAGR during the forecast period for 2026-2035.
AI Therapeutics, Inc., Ares Genetics GmbH, BenevolentAI, BioSymetrics, Cambridge Cancer Genomics (UK), Clover Therapeutics, Congenica Ltd, Others
Artificial Intelligence in Genomics market is segmented on the basis of offering, application, technology type, functionality, and region.
North American region is leading the Artificial Intelligence in Genomics market.